Myra Women'S Hospital Profile
Key Indicators
- Authorised Capital ₹ 0.80 M
as on 07-01-2025
- Paid Up Capital ₹ 0.80 M
as on 07-01-2025
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.64 M
as on 07-01-2025
- Revenue 421.23%
(FY 2021)
- Profit 28.13%
(FY 2021)
- Ebitda 150.94%
(FY 2021)
- Net Worth -69.81%
(FY 2021)
- Total Assets 8.03%
(FY 2021)
About Myra Women'S Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.80 M and a paid-up capital of Rs 0.80 M.
The company currently has active open charges totaling ₹8.64 M.
Sonali Sumit, Anjuri Roy, Ajit Patil, and One other member serve as directors at the Company.
- CIN/LLPIN
U85191MH2015PTC267391
- Company No.
267391
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Aug 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Myra Women'S Hospital?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sonali Sumit  | Director | 30-Sep-2017 | Current |
| Anjuri Roy | Director | 10-Apr-2024 | Current |
| Ajit Patil | Director | 11-Aug-2015 | Current |
| Jaywant Yashwantrao | Director | 11-Aug-2015 | Current |
Financial Performance of Myra Women'S Hospital.
Myra Women'S Hospital Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 421.23% increase. The company also saw a substantial improvement in profitability, with a 28.13% increase in profit. The company's net worth observed a substantial decline by a decrease of 69.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Myra Women'S Hospital?
In 2021, Myra Women'S Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹8.64 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.60 Cr
- Others : 0.26 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2024 | Others | ₹2.64 M | Open |
| 20 Aug 2019 | Hdfc Bank Limited | ₹6.00 M | Open |
How Many Employees Work at Myra Women'S Hospital?
Myra Women'S Hospital has a workforce of 15 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Myra Women'S Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Myra Women'S Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
